29
Views
4
CrossRef citations to date
0
Altmetric
Review

Percutaneous catheter ablation of atrial fibrillation

Pages 693-705 | Published online: 10 Jan 2014

References

  • Roy D, Talajic M, Dorian P et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N. Engl. J. Med.342, 913–920 (2000).
  • Nattel S, Lumer G, Talajic M, Roy D. Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF. Card. Electrophysiol. Rev.7, 211–214 (2003).
  • Gillinov AM. Advances in surgical treatment of atrial fibrillation. Stroke38, 618–623 (2007).
  • Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc. Res.54, 204–216 (2002).
  • Ausma J, van der Velden HM, Lenders MH et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation107, 2051–2058 (2003).
  • Thijssen VL, van der Velden HM, van Ankeren EP et al. Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc. Res.54, 427–437 (2002).
  • Schotten U, Ausma J, Stellbrink C et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation103, 691–698 (2001).
  • Ausma J, Coumans WA, Duimel H, Van der Vusse GJ, Allessie MA, Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc. Res.47, 788–796 (2000).
  • van der Velden HM, Ausma J, Rook MB et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc. Res.46, 476–486 (2000).
  • Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc. Pathol.9, 17–28 (2000).
  • Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation96, 3710–3720 (1997).
  • Ausma J, Dispersyn GD, Duimel H et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J. Mol. Cell. Cardiol.32, 355–364 (2000).
  • Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation92, 1954–1968 (1995).
  • Cheung DW. Pulmonary vein as an ectopic focus in a digitalis-induced arrhythmia. Nature294, 582–584 (1981).
  • Scherf D. Studies on auricular tachycardia caused by aconitine administration. Proc. Soc. Exp. Biol. Med.64, 233–239 (1947).
  • Haissaguerre M, Jais P, Shah DC et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation95, 572–576 (1997).
  • Chen YJ, Chen SA, Chang MS, Lin CL. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc. Res.48, 265–273 (2000).
  • Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation34, 412–422 (1966).
  • Kholova I, Kautzner J. Anatomic characteristics of extensions of atrial myocardium into the pulmonary veins in subjects with and without atrial fibrillation. Pacing Clin. Electrophysiol.26, 1348–1355 (2003).
  • Lin WS, Prakash VS, Tai CT et al. Pulmonary vein morphology in patients with paroxysmal atrial fibrillation initiated by ectopic beats originating from the pulmonary veins: implications for catheter ablation. Circulation101, 1274–1281 (2000).
  • Sanders P, Berenfeld O, Hocini M et al. Spectral analysis identifies sites of high-frequency gradient in paroxysmal but no persistent atrial fibrillation in humans. Circulation110, 3181–3186 (2004).
  • Martin RE, Ellenbogen KA, Lau YR et al. Phased-array intracardiac echocardiography during pulmonary vein isolation and linear ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol.13, 873–879 (2002).
  • Tada H, Oral H, Ozaydin M et al. Response of pulmonary vein potentials to premature stimulation. J. Cardiovasc. Electrophysiol.13, 33–37 (2002).
  • Nakashima H, Kumagai K, Noguchi H, Tojo H, Yasuda T, Saku K. Evaluation of the recurrence of atrial fibrillation after pulmonary venous ablation. J. Cardiol.40, 87–94 (2002).
  • Haissaguerre M, Jais P, Shah DC et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation101, 1409–1417 (2000).
  • Pappone C, Oreto G, Rosanio S et al. Atrial electro-anatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation104, 2539–2544 (2001).
  • Daoud EG, Weiss R, Augostini R et al. Proarrhythmia of circumferential left atrial lesions for management of atrial fibrillation. J. Cardiovasc. Electrophysiol.17, 157–165 (2006).
  • Khaykin Y, Marrouche NF, Saliba W et al. Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm1, 33–39 (2004).
  • Ouyang F, Ernst S, Chun J et al. Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique. Circulation112, 3038–3048 (2005).
  • Kanj MH, Wazni O, Fahmy T et al. Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. J. Am. Coll. Cardiol.49, 1634–1641 (2007).
  • Marrouche NF, Guenther J, Segerson NM et al. Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J. Cardiovasc. Electrophysiol.18(6), 583–588 (2007).
  • Kanj M, Wazni O, Natale A. Pulmonary vein antrum isolation. Heart Rhythm4, S73–S79 (2007).
  • Nadamanee K, McKenzie J, Koser E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol.43, 2054–2060 (2004).
  • Scherlag BJ, Yamanashi WS, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J. Am. Coll. Cardiol.45, 1878–1882 (2005).
  • Scherlag BJ, Patterson E, Po SS. The neural basis of atrial fibrillation. J. Electrocardiol.39, S180–S183 (2006).
  • Pappone C, Santinelli V, Manguso F et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation109, 327–334 (2004).
  • Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation108, 2355–2360 (2003).
  • Karch MR, Zrenner B, Deisenhofer I et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation111, 2875–2880 (2005).
  • Jais P, Hocinic M, Hsu LF et al. Technique and results of linear ablation at the mitral isthmus. Circulation110, 2996–3002 (2004).
  • Hocini M, Jais P, Sanders P et al. Techniques, evaluation and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation. Circulation112, 3688–3696 (2005).
  • Sanders P, Jais P, Hocinic M et al. Electrophysiologic an clinic consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm1, 176–184 (2004).
  • Calo L, Lamberti F, Loricchio ML et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation. J. Am. Coll. Cardiol.47, 2504–2512 (2006).
  • Oral H, Chugh A, Good E et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation113, 1824–1831 (2006).
  • Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation111, 1100–1105 (2005).
  • Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Circulation112, 1214–1222 (2005).
  • Cauchemez B, Extramiana F, Cauchemez S et al. High flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the left atrium. J. Cardiovasc. Electrophysiol.15, 276–283 (2004).
  • Ren JF, Marchilinski FE, Callans DJ et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J. Cardiovasc. Electrophysiol.16, 474–477 (2005).
  • Robbins IM, Colvin EV, Doyle TP et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation98, 1769–1775 (1998).
  • Packer DL, Keelan P, Munger TM et al. Clinical presentation, investigation and management of pulmonary vein stenosis complicating ablation of atrial fibrillation. Circulation16, 1180–1188 (2005).
  • Pappone C, Oral H, Santinelli V et al. Atrioesophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation109, 2724–2726 (2004).
  • Dagres N, Kottkamp H, Piorkowski C et al. Rapid detection and successful treatment of esophageal perforation after radiofrequency ablation of atrial fibrillation: lessons from five cases. J. Cardiovasc. Electrophysiol.17, 1213–1215 (2006).
  • Mesas CE, Pappone C, Lang CCE et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation. J. Am. Coll. Cardiol.4, 1071–1079 (2004).
  • Lustgarten DL, Keane D, Ruskin J. Cryothermal ablation: mechanism of tissue injury and current experience in the treatment of tachyarrhythmias. Prog. Cardiovasc. Dis.41, 481–598 (1999).
  • Skanes AC, Jensen SM, Papp R et al. Isolation of pulmonary veins using a transvenous curvilinear cryoablation catheter: feasibility, initial experience and analysis of recurrences. J. Cardiovasc. Electrophysiol.16, 1304–1308 (2005).
  • Yiu KH, Lau CP, Lee KL, Tse HF. Emerging energy sources for catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol.17, S56–S61 (2006).
  • Nakagawa H, Antz M, Wong T et al. Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol.18, 136–144 (2007).
  • Reddy VY, Houghtaling C, Fallon J et al. Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model. Pacing Clin. Electrophysiol.27, 52–57 (2004).
  • Daoud E, Kalbfleisch S, Hummel J. Intracardiac echocardiography to guide trans-septal left heart catheterization for radiofrequency catheter ablation. J. Cardiovasc. Electrophysiol.10, 358–363 (1999).
  • Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J. Am. Coll. Cardiol.43, 1861–1867 (2004).
  • Mangrum JM, Mounsey JP, Kok LC, DiMarco JP, Haines DE. Intracardiac echocardiography-guided, anatomically based radiofrequency ablation of focal atrial fibrillation originating from pulmonary veins. J. Am. Coll. Cardiol.39, 1964–1969 (2002).
  • Pappone G, Vicedomini G, Manguso F et al. Robotic magnetic navigation for atrial fibrillation ablation. J. Am. Coll. Cardiol.47, 1390–1400 (2006).
  • Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347, 1825–1833 (2002).
  • Epstein AE, Corley SD. Relationship between sinus rhythm, treatment and survival in the Atrial Fibrillation Follow-up Investigation Of Rhythm Management (AFFIRM) study. Circulation109, 1509–1513 (2003).
  • Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol.42, 185–197 (2003).
  • Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus Antiarrhythmic drug therapy in Paroxysmal Atrial Fibrillation: the APAF Study. J. Am. Coll. Cardiol.48, 2340–2347 (2006).
  • Jais P, Cauchemez B, Macle L, Daoud E, Waldo A, Ruskin J. Atrial fibrillation ablation vs antiarrhythmic drugs: a multicenter randomized trial. Heart Rhythm3, 1126 (2006).
  • Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines management of patients with atrial fibrillation. Circulation114, 257–354 (2006).
  • Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA293, 2634–2640 (2005).
  • Knight BP, Oral H, Chugh A et al. Effects of operator experience on the outcome and duration of pulmonary vein isolation. Am. J. Cardiol.91, 673–677 (2003).
  • Haissaguerre M, Jais P, Shah DC et al. Electrophysiology end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation101, 1409–1417 (2000).
  • Marrouche NF, Dresing T, Cole C et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J. Am. Coll. Cardiol.40, 464–474 (2002).
  • Oral H, Knight B, Ozaydin M et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation106, 1256–1262 (2002).
  • Deisenhofer I, Schneider MA, Bohlen-Knauf M et al. Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation. Am. J. Cardiol.91, 159–163 (2003).
  • Arentz T, von Rosenthal J, Blum T et al. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation108, 2484–2490 (2003).
  • Vasamreddy CR, Dalal D, Eldadah Z et al. Safety and efficacy of circumferential pulmonary vein catheter ablation of atrial fibrillation. Heart Rhythm2, 42–48 (2005).
  • Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J. Cardiovasc. Electrophysiol.15, 532–537 (2004).
  • Kanagaratnam L, Tomassoni G, Schweikert R et al. Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing Clin. Electrophysiol.24, 1774–1779 (2001).
  • Kottkamp H, Tanner H, Kobza R et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J. Am. Coll. Cardiol.44, 869–877 (2004).
  • Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med.354, 934–941 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.